Persistent acid-fast bacilli following intravesical bacillus Calmette-Guerin.
Intravesical bacillus Calmette-Guerin immunotherapy has great efficacy in the treatment of superficial transitional cell carcinoma of the bladder. We report a case of persistent acid-fast bacilli contained within granulomas of the bladder, prostate and epididymides 1 year after treatment with intravesical bacillus Calmette-Guerin. Although commonly encountered immediately after therapy, there are no reported cases of persistent acid-fast bacilli following intravesical administration of bacillus Calmette-Guerin.
Linn
R
R
Department of Surgery, University of Florida, Gainesville.
Klimberg
I W
IW
Wajsman
Z
Z
D000283:Administration, Intravesical; D000368:Aged; D001500:BCG Vaccine / Q000009:adverse effects* / Q000627:therapeutic use; D002295:Carcinoma, Transitional Cell / Q000628:therapy*; D004823:Epididymitis / Q000209:etiology*; D006099:Granuloma / Q000209:etiology*; D006801:Humans; D008297:Male; D011472:Prostatitis / Q000209:etiology*; D012307:Risk Factors; D013997:Time Factors; D001745:Urinary Bladder Diseases / Q000209:etiology*; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine